| HIV-positive | HIV-negative | p value | ||||
---|---|---|---|---|---|---|---|
 | Tested | Positive | Prevalence % (95% CIa) | Tested | Positive | Prevalence % (95% CI) |  |
Chlamydia | 123 | 0 | 0.0% (0.0-2.9% | 286 | 11 | 3.8% (1.9-6.8%) | 0.039b |
Gonorrhea | 124 | 0 | 0.0% (0.0-2.9%) | 285 | 0 | 0.0% (0.0-1.3%) | NS |
Syphilis | 126 | 1 | 0.79% (0.02-4.3%) | 291 | 1 | 0.34% (0.01-1.9%) | NS |
Bacterial vaginosis | 123 | 19 | 15.4% (9.6-23.1%) | 283 | 49 | 17.3% (13.1-22.2%) | NS |
Abnormal vaginal flora | 123 | 42 | 34.1% (25.8-43.2%) | 283 | 84 | 29.7% (24.4-35.4%) | NS |
Trichomonas vaginalis | 124 | 9 | 7.3% (3.4-13.3%) | 286 | 13 | 4.5% (2.4-7.6%) | NS |
Yeast | 123 | 9 | 7.3% (3.3-13.4%) | 283 | 19 | 6.7% (4.1-10.3%) | NS |
HSV-1 | 123 | 111 | 90.2% (83.6-94.6%) | 290 | 254 | 87.6% (83.2-91.2%) | NS |
HSV-2 | 124 | 107 | 86.3% (79.0-91.8%) | 290 | 135 | 46.6% (40.7-52.5%) | <0.0001 |
Cytomegalovirus | 126 | 125 | 99.2% (95.7-100%) | 291 | 274 | 94.2% (90.8-96.6%) | 0.018 |
High risk HPV, vaginal | 124 | 60 | 48.4% (39.3-57.5% | 283 | 49 | 17.3% (12.9-21.7% | <0.0001 |
HCV | 126 | 5 | 4.0% (1.3-9.0%) | 290 | 4 | 1.4% (0.38-3.5%) | NS |
HBV infectedc | 126 | 6 | 4.8% (1.8-10.1%) | 291 | 1 | 0.34% (0.01-1.9%) | 0.004b |
HBV everd | 126 | 60 | 47.6% (38.7-56.7%) | 283 | 60 | 21.2% (16.6-26.4%) | <0.0001 |
HBV vaccination | 109 | 72 | 66.1% (56.4-74.9%) | 248 | 109 | 44.0% (37.7-50.4%) | 0.0001 |